Principal investigators James S. Hagood, MD, and Richard C. Boucher, MD, at the UNC School of Medicine, will lead a multinational, $3.5-million project funded through the Chan Zuckerberg Initiative to map crucial cellular roles in human health and disease. Other Marsico Lung Institute researchers in the project are Michelle Hernandez, MD, Scott H. Randell, PhD, and … Read more

David Peden, MD, has been named by UNC-Chapel Hill as the School of Medicine’s Harry S. Andrews Distinguished Term Professor, effective April 25, 2021. Peden is among 68 other professors recently named Distinguished Professors by Carolina. Read the full story here.

Matthew Vogt, MD, PhD, was consulted for a WRAL report on the relatively low number of pediatric COVID-19 hospitalizations in the Triangle area. Read the full story here.

Christine Vigeland, MD, was interviewed for an ABC11 news report detailing how hospital ICUs have reached capacity during the COVID-19 surge. Read the full story and view the video here.

M. Bradley Drummond, MD, was consulted for a WRAL article about the Carolina Stress Initiative, which seeks to address the mental stress of caring for COVID-19 patients. The article, “Carolina Stress Initiative recruiting health care workers for study to develop better mental health therapies,” can be found here.

David Peden, MD, past president of the American Academy of Allergy, Asthma & Immunology, will serve as the academy’s first editor-in-chief of The Journal of Allergy and Clinical Immunology: Global. Read the full story here.

Ilona Jaspers, PhD, and Adam Goldstein, MD, MPH, share their responses to the terms of e-cigarette manufacturer Juul Labs’ settlement in a lawsuit from North Carolina’s attorney general. Read their opinions here on what this means for the state and the future of youth vaping.

The Society’s Hodgkin-Huxley-Katz Prize Lecture is a prestigious biennial lecture, awarded to distinguished physiologists working outside the United Kingdom or Republic of Ireland. Read the fully story here.

Scientists led by UNC School of Medicine researchers Silvia Kreda, PhD, and Rudolph Juliano, PhD, created an improved oligonucleotide therapy strategy with the potential for treating other pulmonary diseases, such as COPD and asthma. Read the full story here.

A study by the Kesimer lab published in Lancet Respiratory Medicine has been profiled in a WRAL TechWire article, “Elevated level of lung protein could be early predictor for COPD, UNC says.” Mehmet Kesimer, PhD, is the study’s senior author, and the lead author is Giorgia Radicioni, PhD. The WRAL article can be read here.